Press-release for stocks for SNY

symbols : SNY crawled time : 11:00

save search

Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 1.45% | O: -0.53% H: 0.61% C: 0.61%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.97% | O: -0.04% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 3.19% | O: 0.13% H: 0.11% C: -1.73%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 2.36% | O: 1.95% H: 0.0% C: 0.0%
research global gastrointestinal therapeutics

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.01% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -0.99% | O: -0.32% H: 0.0% C: 0.0%
IGMS | $7.73 14.52% 12.68% 410K

Health Technology

| -12.7% | O: -0.91% H: 0.0% C: -6.41%

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.01% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -0.99% | O: -0.32% H: 0.0% C: 0.0%
NRIX | $14.125 4.01% 3.86% 690K

Health Technology

| 0.32% | O: 18.35% H: 1.98% C: -5.88%
first update therapeutics financial results

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MLTX | $43.24 5.41% 5.13% 580K

| -7.8% | O: -2.03% H: 2.45% C: 0.48%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.01% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -0.99% | O: -0.32% H: 0.0% C: 0.0%
partnership health research technology skin

Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.27% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -0.55% | O: -0.38% H: 0.95% C: 0.83%
NRIX | $14.125 4.01% 3.86% 690K

Health Technology

| 1.58% | O: 1.26% H: 0.0% C: 0.0%
protein collaboration extension therapeutics sanofi

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.93% | O: -1.77% H: 0.0% C: -1.81%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -3.16% | O: -3.44% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K

Health Technology

| -5.2% | O: -0.4% H: 0.0% C: -5.22%
pharma report universal

XORTX Announces New Clinical Advisory Board Member - March 27, 2024
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -5.71% | O: -0.26% H: 0.0% C: 0.0%
XRTX | News | $2.88 -2.41% 8.3K

Mining, Quarrying, and Oil and ...

| -23.95% | O: 0.0% H: 0.0% C: -5.79%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -4.35% | O: 1.06% H: 0.0% C: 0.0%

Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.56% | O: -100.0% H: NaN% C: Infinity%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -2.1% | O: 0.42% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| -6.19% | O: -1.37% H: 1.15% C: 0.74%
license update application

Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K

Health Technology

| 0.21% | O: 0.03% H: 3.03% C: 1.75%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.65% | O: 0.14% H: 0.24% C: 0.24%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -3.81% | O: -0.03% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -0.55% | O: 0.3% H: 0.0% C: 0.0%
NTLA | $21.535 -1.35% -1.37% 850K

Health Technology

| -22.5% | O: 2.12% H: 0.6% C: -2.54%
GMAB | News | $28.54 -1.48% -1.51% 560K

Health Technology

| -2.99% | O: 1.19% H: 0.47% C: -0.77%
meeting

Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| -6.35% | O: 0.23% H: 0.9% C: -0.68%
praluent fda children genetic cholesterol approval treat injection

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
Published: 2024-03-11 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
FGEN | $1.07 -6.14% -6.54% 1.3M

Health Technology

| -40.56% | O: -1.67% H: 3.95% C: -3.39%
medical

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.64% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -1.03% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K

Health Technology

| -7.78% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
Published: 2024-02-02 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -2.89% | O: -0.93% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K

Health Technology

| -5.27% | O: 1.4% H: 0.28% C: -2.68%
treatment ema

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology